Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY

v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Accumulated Deficit
Balance, shares at Sep. 30, 2020   17,667  
Balance, amount at Sep. 30, 2020 $ 27,378 $ 58,031 $ (30,653)
Share-based compensation 970 $ 970 0
Issuance of stock for restricted stock, shares   600  
Issuance of stock for restricted stock, amount 0 $ 0 0
Sale of common stock in public offering, net of costs, shares   95,833  
Sale of common stock in public offering, net of costs, amount 52,415 $ 52,415 0
Net income 6 $ 0 6
Balance, shares at Sep. 30, 2021   114,100  
Balance, amount at Sep. 30, 2021 80,769 $ 111,416 (30,647)
Share-based compensation 635 $ 635 0
Issuance of stock for restricted stock, shares   350  
Issuance of stock for restricted stock, amount 0 $ 0 0
Net income 19,599 $ 0 19,599
Balance, shares at Sep. 30, 2022   114,450  
Balance, amount at Sep. 30, 2022 $ 101,003 $ 112,051 $ (11,048)